Browse by Medical Category
Research at Mass General
An in-depth look at some of the recent research studies published by researchers at the Massachusetts General Hospital Research Institute.
The research team from the Laboratory for Lipid Medicine and Technology (LLMT) in Massachusetts General Hospital sought to determine if omega-3 fatty acids can alleviate pulmonary and systemic inflammation induced by ambient PM2.5 airborne pollution in urban environments throughout the world.
A study by the Laboratory for Lipid Metabolism at Mass General sought to determine if high concentrations of Omega-3 fatty acids helped to prevent later-life obesity in children who were treated with antibiotics at an early age.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal of all human malignancies and is responsible for hundreds of thousands of deaths each year. Thus, there is an urgent need to improve our understanding of the molecular underpinnings that drive PDAC initiation, progression, and metastasis and to leverage that understanding toward better therapeutic options. A new study by the laboratory of Raul Mostoslavsky, MD, PhD, has identified a potential treatment target.
A team of researchers from Massachusetts General Hospital, including Aaron Leong, MD, recently sought to determine whether people who are genetically disposed to developing type 2 diabetes had a higher rate of mortality compared to those without a genetic disposition.
A recent research study by the research team in the lab of Marcia B. Goldberg, MD, sought to identify the human proteins required for bacterial pathogens to infect human cells.
Back to Top